BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
KLK3
,
cell-cell adhesion
,
HIV infection
,
Endothelial cell
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RNA polymerase core enzyme binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Ovary
Peritoneum
T Lymphocyte (CD4+) of peripheral blood
Fallopian tube
Kidney
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Pyloric ulcer
Multiple-resistant Staphylococcus aureus infection
Hemorrhagic shock
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carbon Black
CGP 60474
flavopiridol
AT 7519
BMS 387032
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TBC1D23
DROSHA
FUBP3
SEPT4
comr
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Liposarcoma and normal fat tissues
Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
Follicular fluid miRNA profiles during the development of the oocyte
Tumor formation by ATG5 KO cells
Carotid arteries from atherogenic ApoE knockout mice with carotid artery injury
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for RNA polymerase core enzyme binding
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Effect of Vitamin D and Calcium on Bone in Pediatric HIV
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Pat…
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in R…
Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Re…
Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Dif…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ